-
Mashup Score: 2Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis - Tramacere, I - 2023 | Cochrane Library - 6 month(s) ago
Collapse all Expand all Background Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects mainly young adults (two to three times more frequently in women than in men) and causes significant disability after onset. Although it is accepted that immunotherapies for people with MS decrease disease activity, uncertainty regarding their relative safety remains….
Source: www.cochranelibrary.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Blood Test for MS Activity Gets FDA Breakthrough Designation - 6 month(s) ago
Roche’s Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Blood Test for MS Activity Gets FDA Breakthrough Designation - 6 month(s) ago
Roche’s Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.
Source: www.medscape.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 6Blood Test Could Predict Future Disability in MS - 6 month(s) ago
Measuring levels of neurofilament light chain in the blood could warn of worsening disability up to 2 years before it occurs.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
Is this earliest of stages a chance to intervene early, or too uncertain to treat?
Source: www.medpagetoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2Next Up in MS Trials: More Insight Into Progressive Disease - 7 month(s) ago
Neurologist Jeremy Chataway brings you the latest on important clinical trials in progressive MS that will help guide the field toward better treatments.
Source: www.medscape.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2'Frame Running' May Help Boost Physical Activity in MS - 7 month(s) ago
People with multiple sclerosis and moderate-to-severe walking disability could engage in physical activity and improve their physical function with an adapted running frame, suggests new research.
Source: www.medscape.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 35Integrin α3 promotes TH17 cell polarization and extravasation during autoimmune neuroinflammation - 7 month(s) ago
Integrin α3 promotes TH17 cell differentiation, proliferation, and transmigration, driving pathogenicity during autoimmune neuroinflammation.
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2Integrin α3 promotes TH17 cell polarization and extravasation during autoimmune neuroinflammation - 7 month(s) ago
Integrin α3 promotes TH17 cell differentiation, proliferation, and transmigration, driving pathogenicity during autoimmune neuroinflammation.
Source: www.science.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 1Ocrelizumab Benefit Confirmed in Older Patients With MS - 7 month(s) ago
The relapse benefit of ocrelizumab in multiple sclerosis is confirmed for the first time in patients 60 and older starting therapy, say researchers in findings they hope will inform choices.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet
What are the risks of therapies for treating #MultipleSclerosis? 📚 🔍 This network meta‐analysis looks at the evidence from 123 trials with 57,682 participants. https://t.co/m3lxosHMJm